Description
Composition:
Each uncoated tablet contains :
Carvedilol IP 3.125 mg
Colour : Titanium Dioxide IP
INDICATION & USE
• Post-MI LV Dysfunction
• Mild to severe CHF (NYHA I-IV)
• Post-MI LV Dysfunction
• Mild to severe CHF (NYHA I-IV)
Each uncoated tablet contains :
Carvedilol IP 3.125 mg
Colour : Titanium Dioxide IP
• Post-MI LV Dysfunction
• Mild to severe CHF (NYHA I-IV)
Shince Pharmaceuticals Pvt Ltd., a division of Surien Pharmaceuticals (P) Ltd., delivers excellence in pharmaceutical manufacturing and innovation worldwide.
Reviews
There are no reviews yet.